US Patent 11918651 Formulations of antibody molecules to dengue virus
Patent 11918651 was granted and assigned to Visterra Inc. on March, 2024 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11918651 Formulations of antibody molecules to dengue virus
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
